Skip to content

Synbiotics in Infants With Cyanotic Congenital Heart Disease

Efficacy of Synbiotics in Infants With Cyanotic Congenital Heart Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01810978
Enrollment
100
Registered
2013-03-14
Start date
2012-10-31
Completion date
2013-05-31
Last updated
2013-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Heart Disease

Keywords

congenital heart disease, probiotic, prebiotic

Brief summary

Infants with congenital heart disease have more frequent infections and exposures to antibiotics than healthy infants. The investigators hypothesized that synbiotics may reduce the rate of sepsis and necrotizing enterocolitis in infants with CHD

Detailed description

Infants with congenital heart disease have more frequent infections and exposures to antibiotics than healthy infants. Probiotics may prevent pathogen colonization in infants with CHD. Therefore, the investigators hypothesized that synbiotics may reduce the rate of sepsis and necrotizing enterocolitis in infants with CHD

Interventions

DIETARY_SUPPLEMENTBifidobacterium lactis plus inulin

5 billion unit Bifidobacterium lactis plus 900 mg inulin per day will be given

DIETARY_SUPPLEMENTMaltodextrin

same amount of maltodextrin per day will be given as placebo

Sponsors

Dr. Sami Ulus Children's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
1 Days to 3 Months
Healthy volunteers
No

Inclusion criteria

* Cyanotic congenital heart disease * infants \>35 weeks of gestational age * Born at or transferred to Sami Ulus CH

Exclusion criteria

* Congenital anomalies of the intestinal tract

Design outcomes

Primary

MeasureTime frame
Sepsis8 weeks

Secondary

MeasureTime frame
Necrotizing enterocolitis8 weeks

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026